• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西乳腺癌早期检测指南。I - 制定方法。

Guidelines for early detection of breast cancer in Brazil. I - Development methods.

作者信息

Migowski Arn, Stein Airton Tetelbom, Ferreira Camila Belo Tavares, Ferreira Daniele Masterson Tavares Pereira, Nadanovsky Paulo

机构信息

Instituto Nacional de Câncer José Alencar Gomes da Silva, Rio de Janeiro, Brasil.

Instituto Nacional de Cardiologia, Rio de Janeiro, Brasil.

出版信息

Cad Saude Publica. 2018 Jun 21;34(6):e00116317. doi: 10.1590/0102-311X00116317.

DOI:10.1590/0102-311X00116317
PMID:29947660
Abstract

Clinical guidelines are traditionally drafted by expert consensus. The benefits of mammographic screening have been questioned in recent years, owing to biases detected in the clinical trials that popularized its widespread use. Meanwhile, growing body of evidence on harms associated with mammographic screening also required a new approach, taking into account the uncertainties on the benefits and a balance between the gains and possible harms from screening. This article discusses the development of the new guidelines for early detection of breast cancer in Brazil, with details on the drafting methods and implications for the new recommendations. The new methodology features systematic literature reviews, assessment of the validity of the evidence, and the balance between each intervention's risks and benefits, ensuring greater transparency, reproducibility, and validity in the drafting process. The new guidelines also include recommendations for cases with suspicious signs and symptoms. The authors provide a detailed discussion of the advantages of the approach as compared to the traditional expert consensus model, as well as the methods' limitations and disadvantages. They also address the implications of various decisions, such as choices on study designs, screening effectiveness outcomes, definition of overdiagnosis, and methods for calculation.

摘要

临床指南传统上是通过专家共识制定的。近年来,由于在推广其广泛使用的临床试验中发现存在偏差,乳腺钼靶筛查的益处受到了质疑。与此同时,越来越多关于乳腺钼靶筛查相关危害的证据也要求采用一种新方法,要考虑到益处的不确定性以及筛查的获益与可能危害之间的平衡。本文讨论了巴西乳腺癌早期检测新指南的制定情况,详细介绍了起草方法以及新建议的影响。新方法的特点包括系统的文献综述、证据有效性评估以及每种干预措施的风险与益处之间的平衡,确保起草过程具有更高的透明度、可重复性和有效性。新指南还包括针对有可疑体征和症状病例的建议。作者详细讨论了该方法与传统专家共识模式相比的优势,以及该方法的局限性和缺点。他们还探讨了各种决策的影响,例如研究设计的选择、筛查有效性结果、过度诊断的定义以及计算方法等。

相似文献

1
Guidelines for early detection of breast cancer in Brazil. I - Development methods.巴西乳腺癌早期检测指南。I - 制定方法。
Cad Saude Publica. 2018 Jun 21;34(6):e00116317. doi: 10.1590/0102-311X00116317.
2
Guidelines for early detection of breast cancer in Brazil. II - New national recommendations, main evidence, and controversies.巴西乳腺癌早期检测指南。II - 新的国家建议、主要证据及争议
Cad Saude Publica. 2018 Jun 21;34(6):e00074817. doi: 10.1590/0102-311X00074817.
3
Guidelines for early detection of breast cancer in Brazil. III - Challenges for implementation.巴西乳腺癌早期检测指南。III - 实施面临的挑战。
Cad Saude Publica. 2018 Jun 25;34(6):e00046317. doi: 10.1590/0102-311X00046317.
4
Breast cancer screening: why, when, and how many?乳腺癌筛查:为何、何时以及筛查多少人?
Clin Obstet Gynecol. 2011 Mar;54(1):125-32. doi: 10.1097/GRF.0b013e318208020d.
5
Controversies regarding mammography, breast self-examination, and clinical breast examination.有关乳腺 X 线摄影术、乳房自我检查和临床乳房检查的争议。
Obstet Gynecol Clin North Am. 2013 Sep;40(3):413-27. doi: 10.1016/j.ogc.2013.05.001. Epub 2013 Jul 25.
6
A systematic assessment of benefits and risks to guide breast cancer screening decisions.系统评估获益与风险以指导乳腺癌筛查决策。
JAMA. 2014 Apr 2;311(13):1327-35. doi: 10.1001/jama.2014.1398.
7
Breast cancer: Updated screening guidelines - much ado about small improvements.乳腺癌:更新后的筛查指南——小改进引发诸多关注。
Nat Rev Clin Oncol. 2016 Mar;13(3):139-40. doi: 10.1038/nrclinonc.2015.232. Epub 2015 Dec 31.
8
Digital Breast Tomosynthesis and the Challenges of Implementing an Emerging Breast Cancer Screening Technology Into Clinical Practice.数字乳腺断层合成技术以及将一种新兴乳腺癌筛查技术应用于临床实践所面临的挑战。
J Am Coll Radiol. 2016 Nov;13(11S):R61-R66. doi: 10.1016/j.jacr.2016.09.029.
9
Impact of Changes to Breast Cancer Screening Guidelines on Healthcare Providers and Patients.乳腺癌筛查指南的变化对医疗服务提供者和患者的影响。
Clin J Oncol Nurs. 2016 Apr;20(2):203-5. doi: 10.1188/16.CJON.203-205.
10
ACR Appropriateness Criteria Palpable Breast Masses.美国放射学会(ACR)乳腺可触及肿块的适宜性标准
J Am Coll Radiol. 2016 Nov;13(11S):e31-e42. doi: 10.1016/j.jacr.2016.09.022.

引用本文的文献

1
Barriers and facilitators of the implementation of mammography screening in the Brazilian public health system: scoping review.巴西公共卫生系统中实施乳房X光检查筛查的障碍与促进因素:范围综述
BMC Public Health. 2025 May 6;25(1):1659. doi: 10.1186/s12889-025-22889-9.
2
Harms and benefits of mammographic screening for breast cancer in Brazil.巴西乳腺钼靶筛查乳腺癌的危害与益处
PLoS One. 2024 Jan 25;19(1):e0297048. doi: 10.1371/journal.pone.0297048. eCollection 2024.
3
A quality evaluation of the clinical practice guidelines on breast cancer using the RIGHT checklist.
使用RIGHT清单对乳腺癌临床实践指南进行质量评估。
Ann Transl Med. 2021 Jul;9(14):1174. doi: 10.21037/atm-21-2884.
4
Sociodemographic and Clinical-pathological Study of Molecular Subtitles of Breast Carcinoma in a Reference Unit of Maranhão.巴西马拉尼昂州参考单位乳腺癌分子亚型的社会人口学和临床病理学研究
Rev Bras Ginecol Obstet. 2020 Dec;42(12):820-828. doi: 10.1055/s-0040-1719147. Epub 2020 Dec 21.
5
Still Controversial: Early Detection and Screening for Breast Cancer in Brazil, 1950-2010s.仍具争议:1950年至21世纪10年代巴西乳腺癌的早期检测与筛查
Med Hist. 2020 Jan;64(1):52-70. doi: 10.1017/mdh.2019.76.
6
[Family Health Strategy, private health care, and inequalities in access to mammography in BrazilEstrategia de Salud Familiar, salud suplementaria y desigualdad en el acceso a la mamografía en Brasil].[巴西的家庭健康战略、私人医疗保健与乳房X光检查的获取不平等:巴西的家庭健康战略、补充医疗保健与乳房X光检查获取方面的不平等]
Rev Panam Salud Publica. 2018 Nov 27;42:e166. doi: 10.26633/RPSP.2018.166. eCollection 2018.